Efficacy and safety of sodium–glucose co‐transporter‐2 inhibitors in kidney transplant recipients with diabetes mellitus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of sodium–glucose co‐transporter‐2 inhibitors in kidney transplant recipients with diabetes mellitus

Published:2024-06-10 Issue:8 Volume:41 Page:
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:Diabet Med

Author:

Buckley SophieAnne¹,Subramaniam Yuvanaa¹²,Mallik Ritwika¹³,Mukuba Dorcas¹,Casabar Mahalia⁴,Ali Omer⁴,Byrne Connor⁴,Chowdhury Tahseen A.¹^ORCID

Affiliation:

1. Department of Diabetes and Metabolism The Royal London Hospital London UK

2. Department of Diabetes and Metabolism Guy's and St Thomas' NHS Foundation Trust London UK

3. Centre for Obesity Research, University College London UK

4. Department of Nephrology The Royal London Hospital London UK

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dme.15383

Reference10 articles.

1. SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis

2. SGLT2 Inhibitors in Diabetic and Non-Diabetic Chronic Kidney Disease

3. Association of British Clinical Diabetologists and Renal Association guidelines on the detection and management of diabetes post solid organ transplantation

4. Cardiometabolic and Kidney Protection in Kidney Transplant Recipients with Diabetes

5. Sodium-glucose cotransporter-2 inhibitors (SGLT2i) in kidney transplant recipients: what is the evidence?

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP